AusMedtech 2023 Presentations
AusMedtech 2023 speakers from the Australian and international medical devices and diagnostics sector generously shared their time and expertise as we discussed the successes, opportunities and challenges to help industry prepare for its changing landscape.
Please find below presentations from keynote, plenary and concurrent session speakers, where they have kindly approved for sharing with delegates (but please not for distribution):
Keynote address: Medical device regulation, an update on the latest
Tracey Duffy, First Assistant Secretary, Therapeutic Goods Administration
Keynote address: ChatGPT, LLMs, and why they really matter
Prof. Anton van den Hengel
Concurrent session: Reimbursement
Paul Dale, Director, Policy, Medical Technology Association of Australia
Rachel David, Chief Executive Officer, Private Healthcare Australia
Concurrent session: Sensors & wearables
Stijn Eeckhoudt, Director Implant Technology Development, Cochlear Technology Centre Belgium
Els Verhulst, Science and Technology Counselor, Flanders Investment & Trade
Concurrent session: The most exciting areas in medtech
A/Prof. Johan Verjans, Deputy director, Australian Institute for Machine Learning
Concurrent session: Money for nothing? The ins and outs of non-dilutive funding programs in Australia
Dr. Masha Somi, CEO, Health and Medical Research Office, Department of Health and Aged Care
Grace Lethlean, CPO, ANDHealth
Stuart Dignam, CEO, MTPConnect
Michelle Goldsmith, Partner, Strategic Project Partners
Concurrent session: The role of incubators and accelerators in the MedTech innovation and commercialization ecosystem
Dr. Katja Beitat, Head of Healthtech, Cicada Innovations
Stephen Blakeney, Innovations Manager, Medical Device Partnering Program
Pete Horsley, Founder, Remarkable – Accelerating Disability Tech
Grace Lethlean, CPO, ANDHealth
Makenzie Thomas, Portfolio Manager, MedTech Actuator
Concurrent session: Game-changing technologies to safeguard Australia
Dr. Kate Shields, Group Leader, Defence Science and Technology Group
Concurrent session: Early-stage Innovation Forum
Richard Kwan, Business Delegate, Masstron Australia Pty Ltd
Dr. Elvis Chidi-ezeama, Founder, Biomicrology Pty Ltd
A/Prof. Michelle Hill, Affiliate, QIMR Berghofer Medical Research Institute
Harold Lubansky, Managing Director, Haemograph P/l
A/Prof. Samuel Lundin, CEO, Biotome Pty Ltd
Jeffrey Ng, CEO, NIRGenie Pty Ltd
Dr. Tony Simula, CEO & Managing Director, Tekcyte Limited
Dr. Mathew Jafarzadeh, Founder, Cosmoaesthetics